MDNews - Lower Hudson/Bronx

May 2013

Issue link: https://viewer.e-digitaledition.com/i/125960

Contents of this Issue

Navigation

Page 9 of 43

COVER FEATURE operation because of comorbidities such as poor cardiac condition, Dr. Papalezova offers ILI, a less invasive form of ILP that features no incisions because blood vessels are accessed percutaneously. The response rate is a little lower than that of ILP, Dr. Papalezova says, but patients may find it preferable to amputation. The patient navigator, Michelle Padua, N.P., schedules an appointment for one of her patients. D E AD LY, B UT PR E VENTAB LE DESPITE BEING ONE of the most succeeding in educating patients and preventable forms of cancer, melanoma encourages physicians to continue has become more prevalent dur- this practice. Patients with risk factors ing the past decade, says Adam J. should be carefully monitored to Friedman, M.D., a dermatologist catch any developing cancerous lesion at Montefiore Medical Center and before it has the chance to progress to assistant professor, Department melanoma, or worse, metastasize to of Physiology & Biophysics, Albert other parts of the body. Risk factors Einstein College of Medicine. include family history of melanoma, Fortunately, melanoma-associated previous skin or other cancer diagnoses, mortality has decreased in this time, multiple moles, atypical moles or moles which Dr. Friedman attributes to that develop after age 50, and history of earlier detection, growing awareness even a single blistering sunburn. and heightened numbers of patients Dr. Friedman emphasizes that early performing self-exams, as well as referral gives patients the best chance a groundswell of public knowledge to receive treatment, whether: regarding risk factors. + surgery, either wide local excision or Primary care physicians play a leading Mohs surgery; role in the prevention of both melanoma + isolated limb perfusion or infusion; and non-melanoma skin cancers. + medical therapy, such as interleukin-2, Dr. Friedman explains that decreasing mortality shows that physicians are a simplified, minimally invasive procedure offered to poor surgical candidates as an alternative to ILP. "We offer ILP to patients who have multiple lesions between the primary site of the melanoma and the regional lymph node basin," Dr. Papalezova explains. "It's offered when the disease cannot be removed by surgery, so the 10 | Lower Hudson/Bronx MD NEWS I MDNEWS.COM interferon, ipilimumab or vemurafenib; + or radiotherapy. only alternative for the patient is an amputation. We know that systemic chemotherapy has a poor response rate, so for people to whom surgery cannot be offered, this is an attractive option. Short of amputation, this procedure has a response rate of up to 80%, and we offer it to salvage the limb." For patients who cannot tolerate the Hospitable Treatment for All While patients are in the expert care of specialists at the Montefiore Einstein Center for Cancer Care's Melanoma/ Sarcoma Program, they are provided leading-edge treatments and cared for by readily accessible ancillary staff. A nurse navigator is available to answer patients' questions, tend to any needs they may have, and coordinate patients' appointments and transition back to their primary dermatologists. Dr. Krishnamurthy says the central location of the center's specialists is convenient for patients, who avoid adding miles to their cars and stress to their lives by having to visit multiple offices for specialty appointments. "For such a devastating disease, it is best to refer these patients to a place where they can receive immediate, advanced care," Dr. Krishnamurthy says. "Many times, physicians send a patient to a surgeon, and then after surgery, the patient may need an oncologist, and so on. This leads to a delay in overall assessment and initiation of treatment. Utilizing a 'one-stop shop' like we do at Montefiore Einstein Center for Cancer Care averts this issue." In addition, a team of social workers, aid officers and clerical staff work to provide patients with low incomes or no insurance a path for care by taking advantage of special aid provided by Medicaid or grants from drug companies themselves. This and other measures ensure that, at Montefiore Einstein Center for Cancer Care, all patients with melanoma are able to receive the appropriate care. For more infor mation about the Melanoma/Sarcoma Program, please visit www.montefiore.org/cancer. I

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - May 2013